Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dolofen is a brand name used for several analgesic and anti-inflammatory pharmaceutical products. Most commonly, it refers to formulations containing ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins. Specific products include Dolofen A, a combination of ibuprofen, paracetamol (acetaminophen), and magnesium trisilicate, and Dolofen Suspension, a pediatric combination of ibuprofen and paracetamol. In some regions, the name is also associated with diclofenac. These medications are primarily indicated for the relief of pain, fever, and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dolofen.